Difference between revisions of "Resource:F64a535d-7159-4263-9f96-1166765a0133"
From The Embassy of Good Science
Marc.VanHoof (talk | contribs) (Created page with "{{Resource |Resource Type=Cases |Title=Harvard scientists disciplined for not declaring ties to drug companies |Is About=. |Important Because=. Website Factual |Import...") |
Marc.VanHoof (talk | contribs) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Resource | {{Resource | ||
|Resource Type=Cases | |Resource Type=Cases | ||
| − | |Title=Harvard | + | |Title=Harvard Scientists Disciplined for Not Declaring Ties to Drug Companies |
| − | |Is About=. | + | |Is About=This is a factual case about three child psychiatrists who failed to disclose consultancy fees that they received from pharmaceutical companies. Between 2000 and 2007, the three researchers received a combined total of $4.2 million from different companies. The three scientists claim that this was an honest mistake, and consequently were "banned from participating in 'industry-sponsored outside activities' for one year, to be followed by a two-year period of close monitoring and a delay in consideration for promotion.<ref>Brian Owens. 2011. Nature news blog. (''Harvard Scientists Disciplined for Not Declaring Ties to Drug Companies : News Blog'', July 2011)</ref> |
| − | |Important Because=. | + | <references /> |
| − | + | |Important Because=It shows the limitations of policies about financial conflict of interests and how discrepencies between national and institutional policies could contribute to confusion. It also shows what consequences may follow from a lack of transparency about the received funds. | |
| − | + | |Important For=Researchers; Funders | |
| − | |||
| − | |||
| − | |||
| − | |Important For=Researchers | ||
}} | }} | ||
{{Link | {{Link | ||
|Has Link=http://blogs.nature.com/news/2011/07/harvard_scientists_disciplined.html | |Has Link=http://blogs.nature.com/news/2011/07/harvard_scientists_disciplined.html | ||
}} | }} | ||
| − | {{Related To}} | + | {{Related To |
| + | |Related To Theme=Theme:6d71bd59-c3bc-4cd5-9c9f-1ab4e53fc320 | ||
| + | }} | ||
{{Tags | {{Tags | ||
| − | |||
|Has Timepoint=4-7-2011 | |Has Timepoint=4-7-2011 | ||
| − | |Has Location=United States | + | |Has Location=United States; Harvard Medical School; Massachusetts General Hospital |
|Has Virtue And Value=Honesty; Respect | |Has Virtue And Value=Honesty; Respect | ||
|Has Good Practice And Misconduct=Conflict of Interest | |Has Good Practice And Misconduct=Conflict of Interest | ||
| − | |Related To Research Area= | + | |Related To Research Area=Basic Medicine; Health; Medicine |
}} | }} | ||
Latest revision as of 17:37, 25 October 2020
ResourcesCases
Harvard Scientists Disciplined for Not Declaring Ties to Drug Companies
What is this about?
This is a factual case about three child psychiatrists who failed to disclose consultancy fees that they received from pharmaceutical companies. Between 2000 and 2007, the three researchers received a combined total of $4.2 million from different companies. The three scientists claim that this was an honest mistake, and consequently were "banned from participating in 'industry-sponsored outside activities' for one year, to be followed by a two-year period of close monitoring and a delay in consideration for promotion.[1]
- ↑ Brian Owens. 2011. Nature news blog. (Harvard Scientists Disciplined for Not Declaring Ties to Drug Companies : News Blog, July 2011)
Why is this important?
It shows the limitations of policies about financial conflict of interests and how discrepencies between national and institutional policies could contribute to confusion. It also shows what consequences may follow from a lack of transparency about the received funds.
